À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
Do injections of platelet-rich plasma improve outcomes in patients with acute Achilles tendon rupture treated nonsurgically?
L’Essentiel
In this well-conducted randomized trial, platelet-rich plasma (PRP) injections were no better than placebo injections in improving pain or function in patients with nonsurgically treated acute Achilles tendon ruptures. The study was too small to determine differences in re-rupture, though. 1b
Référence
Plan de l'etude: Randomized controlled trial (double-blinded)
Financement: Industry
Cadre: Outpatient (specialty)
Sommaire
These authors recruited adult patients (18 to 60 years of age) with a suspected acute Achilles tendon rupture who were evaluated in emergency departments in Denmark within 72 hours of their injury. The patients had their ruptures confirmed by clinical examination and ultrasound. All patients were treated with a continuously worn ankle orthosis that kept the foot plantar flexed for 8 weeks. After the orthosis was applied, the patient was allowed to bear weight. Every 2 weeks, the researchers lessened the degree of plantarflexion. Once the orthosis was removed, the patients wore shoes with a standard 1-cm heel cap. After 9 weeks, all patients began an ankle rehabilitation program designed to improve mobility, balance, plantar flexor function, and strength. The researchers randomized patients to receive 4 ultrasonically guided injections of PRP (n = 20) or isotonic saline (n = 20). They injected the patients every 2 weeks starting within 4 days of the injury. They explicitly told the patients not to look away. (I'm not sure why, but the authors felt they had to include that in the methods.) They evaluated the patients' outcomes at the time of removing the orthosis and again at 3, 4.5, 6, 9, and 12 months after the injury. None of the patients, injecting clinicians, outcome assessors, or statisticians knew which patients received PRP or placebo. One patient in each group re-ruptured their Achilles and dropped out of the study. Based on a variety of measures that included pain, function, mobility, return to activity, range of motion, and so forth, the patients in each group improved at each point in time, and the degree of improvement was similar. After one year, the patients in both groups still had minor and probably not significant functional impairment in the injured ankle compared with the uninjured ankle. The authors did not report rates of adverse events.
Reviewer
Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI
Commentaires
PRP vs unenhanced treatment of ACL tears, non-surgically
I am not sure why this was considered a worthwhile study. When the tendon tears the bleeding does the job, leaving plenty of platelets to supply growth factors, etc., a major part of their role. PRP is valuable where there is damage without fresh bleeding, such as tendinopathies, enthesiopathies, early grade OA. Adding more to a site that already has it is unlikely to make much difference.
achilles tendon rupture
the healing that occurs naturally is large compared to what can be treated.